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In this study, cell microarray technology is used to identify novel human genes associated with CRE pathway activation. By reverse transfection,
expression plasmids containing full-length cDNAs were cotransfected with the reporter plasmid pCRE-d2EGFP to monitor the activation of the
CRE pathway via enhanced green fluorescence protein (EGFP) expression. Of the 575 predominantly novel genes screened, 22 exhibited relatively
higher EGFP fluorescence compared with a negative control. After a functional validation with a dual luciferase reporter system that included both
cis- and trans-luciferase assays, 4 of the 22 genes (RNF41, C8orf32, C6orf208, and MEIS3P1) were confirmed as CRE-pathway activators.
Western blot analysis revealed that RNF41 can promote CREB phosphorylation. These results demonstrate the successful combination of cell
microarray technology with this reporting system and the potential of this tool to characterize functions of novel genes in a highly parallel format.
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quired to decipher these novel genes, thus stimulating the
development of novel technologies. Ziauddin and Sabatini have
developed a promising cell microarray system for the identifica-
tion of the cellular functions of gene products [1]. Expression
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doi:10.1016/j.ygeno.2007.02.004fection reagent and printed on a glass microscope slide at a high
density to form a microarray. The microarray is subsequently
covered with a layer of cells. Cells growing on top of the printed
spots are transfected, resulting in the overexpression of defined
gene products and the formation of a living microarray of
transfected cell clusters within a background of untransfected
cells. Cellular events, such as protein translocation or calcium
fluxes, can be visualized in real time on the transfected cell
microarray. Alternatively, the microarrays can be fixed and exa-
mined with any technique that is compatible with cell growth on
slides, such as immunofluorescence, in situ hybridization, che-
miluminescence, or autoradiography. Due to the potential for
high-throughput analyses and the economy of labor and rea-
gents, cell microarrays have been used to study the subcellular
localization of proteins [1,2], discover new G-protein-coupled
receptor (GPCR) targets [3], screen single-chain antibody
fragments [4] and novel proapoptotic genes [5,6], and study
the structure/function of multiple versions of the v-Src protein
[7].
29L. Tian et al. / Genomics 90 (2007) 28–34In this study, cell microarrays were adopted to perform a cis-
reporting assessment of cAMP-response element (CRE)-path-
way activation in a high-throughput format. Although a com-
bination cell microarray/cis-reporting system has been used to
monitor mitogen-activated protein kinase signal [8], it has not
been validated in follow-up screening studies. Using reverse
transfection, expression plasmids containing full-length cDNAs
were cotransfected with the pCRE-d2EGFP reporter plasmid.
Activation of the CRE pathway was monitored via enhanced
green fluorescence protein (EGFP) expression. Of 575 genes
screened, 22 potentially had roles in activating the CRE
pathway. Subsequent function validation confirmed that 4 of
these genes function in CRE-pathway activation.
Results
Expression of defined cDNAs on HEK293T cell microarrays
The general scheme of cell microarray fabrication is shown in
Fig. 1. Two reverse transfection protocols, the gelatin–DNA
method (GDM) and the lipid–DNA method (LDM), were
developed by Ziauddin et al. [1]. In the GDM procedure,
expression plasmids were mixed with a gelatin solution and
arrayed on slides. The arrays were subsequently incubated with
transfection reagent. For transfection via LDM, expression
plasmids were premixed with the transfection reagent and gela-
tin solution and then printed on slides. After both methods, the
arrays were overlaid with a suspension of adherently growing
cells and incubated until detection assays were performed.
Both methods were tested for uniformity of reverse trans-
fection efficiency over the entire spotted surface, using the
pEGFP plasmid as a reporter. The GDM procedure produced
inconsistent transfection efficiency (Fig. 2a), while a homo-Fig. 1. Schematic of procedure for the fabrication, cell seeding, and assessment
of cDNA cell microarrays.geneous transfection efficiency was obtained via LDM (Fig.
2b). The mean fluorescence via LDM was about twice as large
as that via GDM, but both methods had similar standard de-
viations (Fig. 2c). The combination gave LDM the smaller
coefficient variation (LDM, 21.44%; GDM, 51.29%). Maybe
the formation of transfection complexes in liquid in which both
the DNA and the transfection reagent were free was more ho-
mogeneous than that on the slide surface, where the transfection
reagent was added to fixed plasmids. Consequently, LDM was
adopted for the screening assay.
The transfection efficiency for HEK293T cells via the LDM
was around 50%. A SMP15XB pin deposited approximately
12.5 nl of solution to generate spots with a diameter of 600 μm,
each of which could contain about 700 cells.
To establish the position of each transfected cell cluster
within the microarray, the robotic arrayer was usually prog-
rammed to transfer the same gene to several slides, one of which
was used for position setting. Cells were not seeded on the
position-setting slide, on which the DNA spots were visualized
under a light microscope to record location information. Images
of cell clusters of interest were captured from the background of
a cell lawn based on this location information.
Screen for genes involved in CRE-pathway activation using cell
microarrays
pCRE-d2EGFP was used as a reporter plasmid to determine
whether a cotransfected gene could activate the CRE pathway.
During screening, PFC-PKA (PathDetect, Stratagene, La Jolla,
CA, USA) was used as a positive control, while pcDNA.3.1/
myc-His(−)B (PCDB) (Invitrogen, San Diego, CA, USA) was
the negative control. Cotransfection of different ratios of PFC-
PKA and pCRE-d2EGFP with LDM revealed that the optimal
ratio of pCRE-d2EGFP/PFC-PKA was 3/1 (1.2 μg pCRE-
d2EGFP and 0.4 μg PFC-PKA). Transfection reagent and
gelatin were mixed, and the solution was printed on BD Falcon
CultureSlides in triplicate. The slides were loaded with HEK
293T cells and cultured in a 5% CO2 incubator at 37°C. Signals
were assessed 24 h later and the average fluorescence value was
calculated from three replicates of every gene (Fig. 3). Of 575
genes, 22 exhibited fluorescence values at least twofold greater
than the value of the negative control. The absence of the in-
ternal control and the imperfections in the cell monolayer often
enhanced or falsely compromised the effect of an individual
gene. Therefore, the 22 genes were only putative activators of
the CRE pathway and required subsequent validation.
Validation of the 22 candidates with dual luciferase reporter
assays
The 22 genes were further scrutinized by examining their
activity when traditionally transfected in 96-well plates. In the
cis-luciferase assay, the 22 genes, PKA (positive control), or
the empty PCDB vector (negative control) were cotransfected
with reporter plasmids into HEK293T cells. After 24 h, the cells
were lysed and luciferase was detected. Five of the 22 genes
(RNF41, C8orf32, C6orf208, MEIS3P1, and FAM26B) showed
Fig. 2. Fluorescent images of pEGFP-transfected HEK293T arrays. (a) Reverse transfection using the gelatin–DNA method (GDM). pEGFP (0.8 μg) was mixed with
20 μl of 0.2% gelatin, at a final concentration of 0.18%, and arrayed on the slides. The arrays were incubated with transfection reagent before cell seeding. After 24 h,
the arrays were examined under a fluorescence microscope. Scale bar, 600 μm. (b) Reverse transfection using the lipid–DNA method (LDM). pEGFP (1.6 μg) was
premixed with transfection reagent to form transfection complexes. An equal volume of 0.2% gelatin solution was added to the transfection complexes and then printed
on the slides. After 24 h, the slides were examined under a fluorescence microscope. Scale bar, 600 μm. (c) The mean and standard deviation of fluorescence via the
two methods. MetaMorph image analysis software was used to calculate the fluorescence values of the 6×6 arrays via two methods. The means and standard
deviations of fluorescence were calculated and the line slope indicates the coefficient of variation.
30 L. Tian et al. / Genomics 90 (2007) 28–34higher luciferase activity relative to the negative control (Fig.
4a). A trans-luciferase assay was performed to confirm function
further and exclude nonspecific activation. RNF41, C8orf32,
C6orf 208, and MEIS3P1 showed elevated luciferase activity
(Fig. 4b).
Detection of CREB phosphorylation with Western blotting
Phosphorylation is a prevalent mechanism by which CREB
is regulated in response to cellular signals. To determine whe-
ther the four genes play a role in CREB phosphorylation,
Western blot analysis was performed using anti-phospho-CREB
antibody. Only one gene, RNF41, promoted CREB phosphory-
lation (Fig. 5).
Bioinformatic analysis of the four positive genes
Bioinformatic analysis of the four genes is shown in Table 1.
Of these, two genes (C8orf32 and C6orf208) are novel geneswith previously unreported functions. RNF41 encodes a ubi-
quitin ligase that promotes ubiquitination and degradation of the
epidermal growth factor receptor family member ErbB3 [9],
mediates degradation of the gigantic IAP BRUCE [10], and
regulates parkin stability and activity [11]. The MEIS3P1 gene
appears to be a retrotransposed pseudogene based on its lack of
exons compared to other family members, one of which is found
on chromosome 19 (MEIS3). It does appear to be transcribed
and has an ORF that may encode a protein of size and sequence
similar to those encoded by MEIS3.
Discussion
In the era of functional genomics, an important goal is to
understand the functions of each identified gene. The cis-re-
porting system supplies a useful method for studying the in vivo
effects of a novel gene. But in the face of thousands of novel
genes, candidate genes must be screened in a simple, rapid, and
high-throughput format. The cell microarray system described
Fig. 3. Application of a cell microarray in a screen for novel genes involved in
activation of the CRE pathway. Using the lipid–DNA transfection method,
1.2 μg of pCRE-d2EGFP, 0.4 μg of expression plasmid, transfection reagent,
and gelatin were mixed and printed in triplicate on BD Falcon CultureSlides.
The slides were loaded with HEK293T cells and cultured in a 5% CO2 incubator
at 37°C. After 24 h, the slides were examined and the average fluorescence value
of the three replicates of every gene was calculated. PFC-PKA and empty
plasmid PCDB were used as the positive and negative controls. (a) Overview of
an entire microarray and of a magnified image of 4×4 arrays. Scale bar, 600 μm.
(b–d) Fluorescence images of single spots. Scale bars, 150 μm. (b) PCDB, (c)
PFC-PKA, (d) MEIS3P1. (e) The captured fluorescence images were analyzed
with MetaMorph image analysis software. The average value of the three
replicates of each gene was calculated. Data were expressed as fold value over
the negative control. Twenty-two genes with fluorescence values greater than
twofold the value of the negative control were selected as candidates. The x axis
indicates the serial numbers of gene clones in our cDNA library. The red arrow
and spots indicate respectively the positive control PKA and the 22 candidates.
(For interpretation of the references to colour in this figure legend, the reader is
referred to the web version of this article.)
31L. Tian et al. / Genomics 90 (2007) 28–34by Ziauddin and Sabatini opens a window to high-throughput
screening [1]. High-throughput screens for novel genes in-
volved in biological processes of interest can be conducted with
the introduction of cell microarray detection assays. The cell
microarray approach has proved useful in the work of several
groups [1–7]. In this study, we combined a cis-reporting assay
and cell microarray system to screen successfully for novel ac-
tivators of the CRE pathway. The detection assays on the slides
did not allow cell disruption, which is needed in the luciferase
reporter format. Therefore, d2EGFP (one variant of EGFP) was
chosen instead as the reporter. A mixture of pCRE-d2EGFPreporter plasmid, the uncharacterized gene, and transfection
reagent was printed on slides to form a microarray. After HEK
293T cells were seeded on the microarray, the cells growing on
the printed spots incorporated plasmids and overexpressed
proteins.
If cotransfection results in the activation of an endogenous
protein kinase that, in turn, activates CREB, then d2EGFP ex-
pression is stimulated. The green fluorescence of d2EGFP can be
detected with fluorescence microscopy. To observe the fluor-
escent signals on one slide at different time points and eliminate
fixation, which might disrupt the cell monolayer, we printed
plasmids on CultureSlides, using uniform spots. A transfection
efficiency of 50% can be obtained with this method.
The different transfection efficiencies over the entire spotted
area and the nonhomogeneity of the cell monolayer can cause
differential fluorescent signal strengths among the genes. It is
normal for the arrays to yield some false-positive genes. Only 5
of the 22 candidates were validated as CRE pathway activators
using the cis-luciferase reporter assay in 96-well plates. It
would be better to introduce another plasmid containing a
strong promoter as the internal control. For example, one can-
didate could be pDsRed2, whose expression is little affected by
the cotransfected gene products. When capturing images, both
the green and the red signals would be collected and then the
green fluorescence value of the genes could be normalized by
the red internal control. However, the lower transfection
efficiency of cotransfecting three plasmids limits the introduc-
tion of the internal control. Therefore, a permanent cell line
stably expressing the reporter and the internal plasmids could be
used to improve transfection efficiency and thus increase
specificity.
In addition, the pCRE-luc used in the validation assay in 96-
well plates contained a CRE sequence different from that in
pCRE-d2EGFP used in the cell microarray. The two CRE se-
quences share a similar consensus sequence, but different flan-
king sequences. The different CRE sequences might partly
result in the high false-positive rate. Of the five genes, only
FAM26B did not show higher luciferase activity relative to the
negative control in the trans-luciferase assay. FAM26B may
play an important role in activation of other signal pathways,
whose transcription factors nonspecifically activate the CRE
pathway.
To determine whether the four validated genes could pro-
mote the phosphorylation of CREB, we performed Western blot
analysis using anti-phosphorylated-CREB antibody. Only one
gene, RNF41, showed an obvious promotion effect on the
phosphorylation of CREB. Although CREB phosphorylation is
the prevalent mechanism in CRE-pathway activation [12],
CRE-pathway activation in a CREB-phosphorylation-indepen-
dent manner has been noted. It is clear that in addition to CREB
phosphorylation, processes such as recruitment, regulation of
coactivators, and coupling to the basal transcription machinery
can present additional mechanisms by which the CRE pathway
can be activated. The coactivator CBP and its p300 analog are
believed to activate gene expression by interacting with com-
ponents of the general transcriptional machinery [13–15] and
by chromatin acetylation [16,17]. Grewal et al. reported that in
Fig. 4. Activation of CRE pathway by four genes. In the cis- and trans-luciferase reporter assays, HEK293T cells in 96-well plates were transfected with reporter
plasmids, an internal control plasmid pRL-TK, and target gene expression plasmids. PKA and the empty plasmid PCDB were used as positive and negative controls.
After 24 h, the cells were harvested, lysed, and examined for luciferase activity. Firefly luciferase activity was normalized to that of Renilla, and data were expressed as
a fold value over the negative control. Each bar represents the mean±SE of three independent treatments. (a) The cis-luciferase assay for the effect of 22 candidates on
CRE-pathway activation. The black bars indicate the five genes with higher luciferase activity relative to the negative control. Student’s t tests were conducted,
*p<0.05, **p<0.01. (b) The trans-luciferase assay for the effect of the five genes on CRE-pathway activation. Four genes (RNF41, C8orf32, C6orf208, and
MEIS3P1) showed elevated luciferase activity relative to the negative control. Student’s t tests were conducted, p<0.05.
32 L. Tian et al. / Genomics 90 (2007) 28–34PC12 cells, a high level of cAMP not only can phosphorylate
CREB via PKA directly, but also requires a Rap1–ERK path-
way to activate a downstream component of CREB phospho-
rylation and coactivator CBP recruitment [18].In addition, the
activity of the transcriptional coactivator CBP has been reportedFig. 5. The RNF41 gene promotes phosphorylation of CREB at Ser133.
HEK293T cells were transfected with target gene expression plasmids. The cells
were harvested and lysed 24 h later. Cell lysates were collected in SDS sample
buffer, resolved by SDS–polyacrylamide gel electrophoresis, and analyzed for
phospho-CREB by Western blotting (top). The blots were then stripped and
reprobed for CREB (middle). β-Actin antibody was used to confirm equal lane
loading with protein (bottom).to be regulated by a variety of kinases, including PKA,
CaMKIV, and ERK, possibly by direct phosphorylation [19–
24]. Thus, the three genes that did not show a promotional effect
on CREB phosphorylation may work downstream of CREB
phosphorylation, particularly at the level of coactivators. The
detailed mechanism by which the four identified genes activate
the CRE pathway requires further study. The MESI3P1 pseu-
dogene lacks three exons compared to MESI3; however, both
genes encode proteins of similar size and sequence and contain
the same homeodomain, which is a one-of-a-kind DNA binding
domain involved in the transcriptional regulation of key eu-
karyotic developmental processes. Therefore, we can speculate
that MESI3 may also activate the CRE pathway, a matter that
also requires subsequent investigation.
In summary, cell microarray technology was used to achieve
a high-throughput cis-reporting system. After initial screening
and subsequent validation, we found 4 of 575 genes capable of
CRE-pathway activation. This application can also be adapted
to screens for novel genes involved in the activation of other
signaling pathways, such as nuclear factor κB, nuclear factor of
Table 1
Results of bioinformatic analysis of four positive genes
Gene
RNF41 C6orf208 C8orf32 MEIS3P1 a
Gene description Ring finger protein 41 Chromosome 6 ORF 208 Chromosome 8 ORF 32 Homo sapiens Meis1 homolog
3 (mouse) pseudogene 1
Accession No. NM_005785 NM_025002 NM_018024 NR_002211
UniGene Hs.591031 Hs.287553 Hs.18029 Hs.356135
Map 12q13 6q27 8q24 17p1
Gene ID 10193 80069 55093 4213
No. of exons 7 3 6 1
Expression profile
(top two)
Wide Wide Hypothalamus, testis Thyroid, adrenal cortex
No. of amino acids 317 128 205 226
pI 5.75 8.17 5.46 4.96
SignalP No No No No
CCD Ring-finger No No Homeodomain
TMHMM No No No No
Subcellular location 47.8% cytoplasmic 47.8% nuclear,
43.5% mitochondrial
69.6% cytoplasmic 52.2% nuclear
Functional article 5 0 0 0
a The gene MEIS3P1 appears to be a retrotransposed pseudogene based on its lack of exons compared to other family members, one of which is found on
chromosome 19 (MEIS3).
33L. Tian et al. / Genomics 90 (2007) 28–34activated T cells, and activator protein-1, and to demonstrate
that cell microarrays are a powerful technique in elucidating the
functions of thousands of novel genes.Materials and methods
cDNA library
A previously constructed cDNA library containing 575 genes was used as
the source of screened genes [25]. Two-step PCR was used to amplify target
genes with “hypothetical,” “predicted,” “putative,” or “unknown” in their
definition and fewer than three functional research articles from the human
RefSeq database (http://www.ncbi.nlm.nih.gov/projects/RefSeq/). The purified
PCR products were cloned into a pGEM-T Easy vector (Promega, Madison, WI,
USA), sequenced using the ABI Prism 3100 genetic analyzer (Applied
Biosystems, Foster City, CA, USA), and subcloned into the EcoRI site of the
mammalian expression vector pcDNA.3.1/myc-His(−)B (PCDB) (Invitrogen).
The cloning project is still under way in our laboratory to amplify the library,
which can be queried by the database (http://61.49.28.140/gene/).
Cell culture and reverse transfection
293T cells (ATCC: CRL-11268) were grown in Dulbecco’s modified Eagle
medium (Hyclone, Logan, UT, USA), supplemented with 10% FBS and 2 mM
L-glutamine, in a 5% CO2 incubator at 37°C. Reverse transfection was based on
the protocol published by Ziauddin et al. [1].
For the GDM, 0.6 μg of pCRE-d2EGFP (Clontech, Palo Alto, CA, USA)
and 0.2 μg of expression plasmids were added to 20 μl of 0.2% (w/v) gelatin
solution (G-9391; Sigma–Aldrich, St. Louis, MO, USA), the final concentration
of which was 0.18%. The DNA–gelatin solution was printed in triplicate on
CultureSlides (BD Falcon) using an ArrayIt SpotBot personal microarray robot
(TeleChem, USA) and ArrayIt Stealth microspotting pins, SMP15XB (Tele-
Chem). CultureSlides were used because the surface allowed for the printing of
small, well-formed spots and detection at many different time points after
reverse transfection. Before the microarrays were printed, 20 μl of gelatin–DNA
solution was loaded into a round-bottomed, 384-well polypropylene microtiter
plate. All printing was done at room temperature with 55% humidity. Using
SMP15XB pins, the printed spots had diameters of 600 μm and were printed
750 μm apart. After printing, the slides were stored at room temperature in a dry
atmosphere until further processing.Before seeding, the spotted area was incubated with transfection reagent
(Effectene Transfection Kit; Qiagen, Valencia, CA, USA) in an incubation
chamber (Baio Technology, China). The transfection reagent mix was prepared
as follows: 16 μl of enhancer (from Effectene Kit) was added to 150 μl of DNA-
condensation buffer (EC buffer from Effectene Kit) and incubated for 5 min at
room temperature. Twenty-five microliters of Effectene transfection reagent was
added and, after being lightly vortexed for 3-4 s, the solution was placed in the
incubation chamber for 20 min at room temperature. After the transfection
reagent and the incubation chamber were removed, cells were overlaid on the
slide for transfection.
For the LDM, 1.2 μg of pCRE-d2EGFP (Clontech), 0.4 μg of expression
plasmids, and 1.5 μl of enhancer were added into 15 μl of EC buffer con-
taining 0.4 M sucrose. The mixture was incubated for 5 min at room
temperature before 5 μl of Effectene transfection reagent was added,
followed by a 10-min incubation at room temperature. A 1× volume of
0.05% (w/v) gelatin (G-9391; Sigma–Aldrich) was mixed with the solution
to complete the transfection master mix. Subsequently, 20 μl was pipetted into a
well of a 384-well plate and then transferred to the CultureSlides as described
above.
HEK293T cells (8×105) in 3 ml of Dulbecco’s modified Eagle medium
(DMEM) (Hyclone) supplemented with 10% FBS and 2 mM L-glutamine were
seeded on a printed culture slide and cultured in a 5% CO2 incubator at 37°C for
24 h.
Image capture and analysis
Images of arrays were captured at 10× magnification with an automated
fluorescence microscope (Axiovert 200M; Zeiss, Germany) and analyzed with
the MetaMorph 6.3 image analysis program (Molecular Devices, Sunnyvale,
CA, USA). MetaMorph assumed that edges of cells are indicated by large
changes in gray-scale level over a very short distance. The target cells were
automatically bounded by selecting an accurate threshold range and setting the
lower value of cell area as 100 and shape factor as 0.7. Total fluorescence was
calculated according to the expression level of EGFP. The average value of the
three replicate images of one gene represented the magnitude of the effect on
CRE-pathway activation.
Cis-luciferase reporter assay
HEK293T cells were seeded in 96-well plates at a density of 1×104/well.
After 24 h, cells in each well were transiently cotransfected with 50 ng of pCRE-
34 L. Tian et al. / Genomics 90 (2007) 28–34luc plasmid (PathDetect, Stratagene), 5 ng of internal control plasmid pRL-TK
(Promega), and 50 ng of target gene expression plasmids using Vigorous
transfection reagent (Vigorous Instruments (Beijing) Co., Ltd., China) according
to standard protocols. The cells were lysed 24 h after transfection in 40 μl of
standard lysis buffer (Promega), after which 10 μl of the cell lysates was assayed
for both firefly and Renilla luciferase activity using a GENios Pro reader (Tecan,
Switzerland). The results were calculated and expressed as the ratio of firefly to
Renilla luciferase activity. The assays were performed three times with three
replicates per experiment.
Trans-luciferase reporter assay
As described above in the cis-luciferase reporter assay, HEK293T cells were
grown in 96-well plates and transfected with Vigorous transfection reagent
(Vigorous Instruments). The cells were lysed 24 h after transfection and the cell
lysates were assayed for firefly and Renilla luciferase activity. The only
modification was the plasmids used for cotransfection: 4 ng of pFA2-CREB
(PathDetect, Stratagene), 40 ng of pFR-Luc (PathDetect, Stratagene), 50 ng of
target gene expression plasmids, and 4 ng of the internal control pRL-TK
(Promega).
Western blot analysis
Phospho-CREB was detected using Western blot analysis. HEK293T cells
were seeded into a 96-well plate at approximately 2×105 cells/well and grown
in DMEM with 10% FBS for 24 h. Transfections were performed using
Vigorous transfection reagent and 2 μg of target gene expression plasmids,
2 μg of the empty plasmid PCDB (negative control), or 2 μg of pFC-PKA
(positive control) in each well. Twenty-four hours after transfection, the cells
were harvested and incubated with 100 μl of lysis buffer (1× PBS, 1% NP-40,
0.5% sodium deoxycholate, 0.1% SDS) on ice for 30 min and centrifuged at
4°C (12,000 rpm, 10 min). The aqueous phase was extracted and reserved.
Total protein concentration was measured with a BCA protein assay kit (Pierce,
Rockford, IL, USA) according to the manufacturer’s instructions. Thirty
micrograms of total protein was separated by electrophoresis through an 8%
SDS–PAGE gel and transferred to a nitrocellulose membrane. The membrane
was blocked in TBST buffer (Biosea Biotechnology, China) containing 5%
nonfat dry milk for 2 h at room temperature. The membrane was then
incubated in TBST with 5% nonfat dry milk containing anti-phospho-CREB
1:1000 (Cell Signaling, USA) overnight at 4°C. The membrane was then
washed in TBST and incubated with secondary anti-rabbit IgG-coupled HRP
antibody 1:10000 (Cell Signaling). After 60 min, blots were washed with
TBST and visualized by enhanced chemiluminescence (Pierce). The membrane
was stripped in 0.1 M glycine (pH 2.5) for 1 h, washed in TBST for 15 min,
and reprobed with anti-CREB 1:1000 (Cell Signaling). β-Actin antibody
(Santa Cruz Biotechnology, Santa Cruz, CA, USA) was used to confirm equal
lane loading with protein.
Bioinformatic analysis of four positive genes
Chromosomal localization and structure were analyzed with reference to the
HTGS database (http://www.ncbi.nlm.nih.gov). The gene expression profiling
was searched using GNF SymAtlas version 1.0.4 (http://symatlas.gnf.org/
SymAtlas/) and the UniGene database (http://www.ncbi.nlm.nih.gov/UniGene/).
The transmembrane analyses were performed using the Expasy Web site (http://
www.cbs.dtu.dk/services/TMHMM-2.0/). The putative cleavage site of signal
peptides was predicted using the SignalP server (http://www.cbs.dtu.dk/services/
SignalP). PSORT II (http://psort.nibb.ac.jp/) software was used to analyze the
protein localization. Protein domains were searched by the NCBI Conserved
Domain Database (http://www.ncbi.nlm.nih.gov/Structure/cdd/cdd.shtml).
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